Dr. Josef Machac received his undergraduate degree of Bachelor in Science, Magna Cum Laude, in 1975 from Brown University, where he received an M.D. in 1978. He did his internship and residency in internal medicine at The Mount Sinai Hospital between 1978 and 1981, and between 1981 and 1983, a residency in nuclear medicine. This was followed be a fellowship in nuclear cardiology from 1983 to 1984, and a fellowship in clinical cardiology from 1985 to 1986. Dr. Machac is board certified in internal medicine, nuclear medicine, and cardiology.
Dr. Machac has been an attending in nuclear cardiology from 1984 to the present time. He became Director of Nuclear Cardiology in 1988 and held that position until 1996. In 1993, he became Director of Nuclear Medicine. In 1985, he because Assistant Professor in Medicine, and in 1993, Associate Professor in Radiology. In 2003, he became Professor in Radiology.
Throughout his career in nuclear cardiology, Dr. Machac has been responsible for many innovations in diagnostic cardiology at Mount Sinai. This includes the introduction of SPECT (single photon emission tomography) cardiac imaging, pharmacological stress imaging, imaging with Tc-99m labeled perfusion agents, myocardial viability imaging, and more recently, cardiac PET imaging.
Dr. Machac has delivered many invited lectures at Mount Sinai, at regional, national, and international meetings and symposia, has organized numerous educational symposia at regional and national meetings, and recently was president of the Cardiovascular Council of the Society of Nuclear Medicine. He has authored or coauthored many papers and numerous chapters.
At the present time, Dr. Machac is director of the Clinical PET Center and Nuclear Medicine at Mount Sinai, which offer high quality state-of-the art cardiac imaging for diagnosis and evaluation of coronary artery disease, and myocardial viability in patients with poor cardiac function. He also sees patients in the cardiac clinic and Faculty Practice Associates' suite.
American Board of Internal Medicine
MD, Brown University
Residency, Internal Medicine
Mount Sinai Hospital
Residency, Nuclear Medicine
Mount Sinai Hospital
Fellowship, Nuclear Cardiology
Mount Sinai Hospital
Mount Sinai Hospital
Czech, English, French, German, Russian, Spanish
GEMINI TF PET/MR Clinical Investigation
The purpose of this study is to establish the imaging performance of the new (first in the world) PET/MR (Positron Emission Tomography/Magnetic Resonance) imaging system. The Gemini TF PET/MR provides whole-body PET and MR imaging and is capable of running in combination as...
Heiba SI, Jiang M, Rivera J, Genden E, Inabnet W, Machac J, Kostakoglu L. Direct comparison of neck pinhole dual-tracer and dual-phase MIBI accuracies with and without SPECT/CT for parathyroid adenoma detection and localization. Clinical nuclear medicine 2015 Jun; 40(6).
Graber E, Regelmann MO, Annunziato R, Machac J, Rapaport R. The role of ¹²³I imaging in the evaluation of infants with mild congenital hypothyroidism. Hormone research in pædiatrics 2015; 83(2).
Patil VV, Sideras P, Machac J. PET/CT presentation of primary effusion lymphoma-like lymphoma unrelated to human herpes virus 8, a rare NHL subtype. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India 2014 Jul; 29(3).
Mitsis EM, Bender HA, Kostakoglu L, Machac J, Martin J, Woehr JL, Sewell MC, Aloysi A, Goldstein MA, Li C, Sano M, Gandy S. A consecutive case series experience with [18 F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition. Molecular neurodegeneration 2014; 9.
Bucerius J, Mani V, Wong S, Moncrieff C, Izquierdo-Garcia D, Machac J, Fuster V, Farkouh ME, Rudd JH, Fayad ZA. Arterial and fat tissue inflammation are highly correlated: a prospective 18F-FDG PET/CT study. European journal of nuclear medicine and molecular imaging 2014 May; 41(5).
Bucerius J, Mani V, Moncrieff C, Machac J, Fuster V, Farkouh ME, Tawakol A, Rudd JH, Fayad ZA. Optimizing 18F-FDG PET/CT imaging of vessel wall inflammation: the impact of 18F-FDG circulation time, injected dose, uptake parameters, and fasting blood glucose levels. European journal of nuclear medicine and molecular imaging 2014 Feb; 41(2).
Heiba S, Kolker D, Ong L, Sharma S, Travis A, Teodorescu V, Ellozy S, Kostakoglu L, Savitch I, Machac J. Dual-isotope SPECT/CT impact on hospitalized patients with suspected diabetic foot infection: saving limbs, lives, and resources. Nuclear medicine communications 2013 Sep; 34(9).
Sideras PA, Heiba S, Machac J, Hechtman J, Vatti S. Mycobacterial pseudotumor of the plantar fascia: how common is it?. Clinical imaging; 37(4).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Machac did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.